Have you been paying attention to shares of HumanaHUM ? Shares have been on the move with the stock up 4.1% over the past month. HUM hit a new 52-week high of $301.81 in the previous session. Humana has gained 21.5% since the start of the year compared to the 1.5% move for the Medical sector and the 12% year-to-date return for its peer group.
What's Driving the Outperformance?
The stock has a great record of positive earnings surprises, having beaten the Zacks Consensus Estimate in each of the last four quarters. In its last earnings report on May 2, 2018, Humana reported EPS of $3.36 versus the Zacks Consensus Estimate of $3.21 while it beat the consensus revenue estimate by 0.39%.
For the current fiscal year, Humana is expected to post earnings of $13.99 per share on $56.22 billion in revenues. This represents a 19.47% change in EPS on a 4.56% change in revenues. For the next fiscal year, the company is expected to earn $16.98 per share on $60.73 billion in revenues. This represents a year-over-year change of 21.37% and 8.03%, respectively.
Humana may be at a 52-week high right now, but what might the future hold for HUM? A key aspect of this question is taking a look at valuation metrics in order to determine if the company is due for a pullback from this level.
On this front, we can look at the Zacks Style Scores, as they provide investors with an additional way to sort through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. The idea behind the style scores is to help investors pick the most appropriate Zacks Rank stocks based on their individual investment style.
Humana has a Value Score of A. The stock's Growth and Momentum Scores are A and B, respectively, giving the company a VGM Score of A.
In terms of its value breakdown, the stock currently trades at 21.6X current fiscal year EPS estimates. On a trailing cash flow basis, the stock currently trades at 19.7X versus its peer group's average of 14.6X. Additionally, the stock has a PEG ratio of 1.56. This isn't enough to put the company in the top echelon of all stocks we cover from a value perspective.
Humana Inc. Price and Consensus
We also need to look at the Zacks Rank for the stock, as this supersedes any trend on the style score front. Fortunately, Humana currently has a Zacks Rank of #2 (Buy) thanks to rising earnings estimates.
Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 and Style Scores of A or B, it looks as if Humana passes the test. Thus, it seems as though HUM shares could have a bit more room to run in the near term.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.